N

NovaBridge Biosciences
D

NBP

1.78000
USD
0.02
(1.14%)
مغلق
حجم التداول
9,714
الربح لكل سهم
-1
العائد الربحي
-
P/E
-4
حجم السوق
205,854,339
أصول ذات صلة المقالات
المزيد

العنوان: NovaBridge Biosciences

القطاع: الرعاية الصحية
الصناعة: Biotechnology
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.